0001209191-20-024231.txt : 20200413
0001209191-20-024231.hdr.sgml : 20200413
20200413171802
ACCESSION NUMBER: 0001209191-20-024231
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200413
FILED AS OF DATE: 20200413
DATE AS OF CHANGE: 20200413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax Management 4 G.P. (2015) Ltd.
CENTRAL INDEX KEY: 0001726334
STATE OF INCORPORATION: L3
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39264
FILM NUMBER: 20789381
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax (Israel) IV, L.P.
CENTRAL INDEX KEY: 0001726039
STATE OF INCORPORATION: E9
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39264
FILM NUMBER: 20789382
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax (Cayman) IV L.P.
CENTRAL INDEX KEY: 0001726029
STATE OF INCORPORATION: E9
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39264
FILM NUMBER: 20789383
BUSINESS ADDRESS:
STREET 1: 4 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 4 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax (China) IV L.P.
CENTRAL INDEX KEY: 0001726030
STATE OF INCORPORATION: E9
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39264
FILM NUMBER: 20789384
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET, BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax Late Stage Fund L.P.
CENTRAL INDEX KEY: 0001793769
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39264
FILM NUMBER: 20789385
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET
STREET 2: BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: L3 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET
STREET 2: BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: L3 46140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pontifax Late Stage GP Ltd.
CENTRAL INDEX KEY: 0001793770
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39264
FILM NUMBER: 20789386
BUSINESS ADDRESS:
STREET 1: 14 SHENKAR STREET
STREET 2: BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: L3 46140
BUSINESS PHONE: 972-9-9725617
MAIL ADDRESS:
STREET 1: 14 SHENKAR STREET
STREET 2: BEIT OFEK
CITY: HERZLIYA PITUACH
STATE: L3
ZIP: L3 46140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Keros Therapeutics, Inc.
CENTRAL INDEX KEY: 0001664710
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 120 (BLD E)
STREET 2: LEDGEMONT TECHNOLOGY CENTER
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-513-8774
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 120 (BLD E)
STREET 2: LEDGEMONT TECHNOLOGY CENTER
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-13
0
0001664710
Keros Therapeutics, Inc.
KROS
0001726334
Pontifax Management 4 G.P. (2015) Ltd.
14 SHENKAR STREET, BEIT OFEK
HERZLIYA PITUACH
L3
46140
ISRAEL
0
0
1
0
0001726039
Pontifax (Israel) IV, L.P.
14 SHENKAR STREET, BEIT OFEK
HERZLIYA PITUACH
L3
46140
ISRAEL
0
0
1
0
0001726029
Pontifax (Cayman) IV L.P.
14 SHENKAR STREET, BEIT OFEK
HERZLIYA PITUACH
L3
46140
ISRAEL
0
0
1
0
0001726030
Pontifax (China) IV L.P.
14 SHENKAR STREET, BEIT OFEK
HERZLIYA PITUACH
L3
46140
ISRAEL
0
0
1
0
0001793769
Pontifax Late Stage Fund L.P.
14 SHENKAR STREET, BEIT OFEK
HERZLIYA PITUACH
L3
46140
ISRAEL
0
0
1
0
0001793770
Pontifax Late Stage GP Ltd.
14 SHENKAR STREET, BEIT OFEK
HERZLIYA PITUACH
L3
46140
ISRAEL
0
0
1
0
Common Stock
2020-04-13
4
C
0
1363542
A
1734395
I
See footnote
Common Stock
2020-04-13
4
C
0
663825
A
844371
I
See footnote
Common Stock
2020-04-13
4
C
0
737226
A
937735
I
See footnote
Common Stock
2020-04-13
4
C
0
169307
A
1903702
I
See footnote
Common Stock
2020-04-13
4
C
0
82425
A
926796
I
See footnote
Common Stock
2020-04-13
4
C
0
91538
A
1029273
I
See footnote
Common Stock
2020-04-13
4
C
0
68654
A
68654
I
See footnote
Common Stock
2020-04-13
4
C
0
163612
A
2067314
I
See footnote
Common Stock
2020-04-13
4
C
0
88460
A
1015256
I
See footnote
Common Stock
2020-04-13
4
C
0
79653
A
1108926
I
See footnote
Common Stock
2020-04-13
4
C
0
36858
A
105512
I
See footnote
Common Stock
2020-04-13
4
P
0
194203
16.00
A
2261517
I
See footnote
Common Stock
2020-04-13
4
P
0
94546
16.00
A
1109802
I
See footnote
Common Stock
2020-04-13
4
P
0
105000
16.00
A
1213926
I
See footnote
Common Stock
2020-04-13
4
P
0
43750
16.00
A
149262
I
See footnote
Series A Preferred Stock
2020-04-13
4
C
0
1363542
0.00
D
Common Stock
1363542
0
I
See footnote
Series A Preferred Stock
2020-04-13
4
C
0
663825
0.00
D
Common Stock
663825
0
I
See footnote
Series A Preferred Stock
2020-04-13
4
C
0
737226
0.00
D
Common Stock
737226
0
I
See footnote
Series B-1 Preferred Stock
2020-04-13
4
C
0
169307
0.00
D
Common Stock
169307
0
I
See footnote
Series B-1 Preferred Stock
2020-04-13
4
C
0
82425
0.00
D
Common Stock
82425
0
I
See footnote
Series B-1 Preferred Stock
2020-04-13
4
C
0
91538
0.00
D
Common Stock
91538
0
I
See footnote
Series B-1 Preferred Stock
2020-04-13
4
C
0
68654
0.00
D
Common Stock
68654
0
I
See footnote
Series C Preferred Stock
2020-04-13
4
C
0
163612
0.00
D
Common Stock
163612
0
I
See footnote
Series C Preferred Stock
2020-04-13
4
C
0
88460
0.00
D
Common Stock
88460
0
I
See footnote
Series C Preferred Stock
2020-04-13
4
C
0
79653
0.00
D
Common Stock
79653
0
I
See footnote
Series C Preferred Stock
2020-04-13
4
C
0
36858
0.00
D
Common Stock
36858
0
I
See footnote
Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date.
The securities are held by Pontifax (Israel) IV, L.P. ("Israel IV"). Pontifax Management 4 G.P. (2015) Ltd. ("Management 4") is the ultimate general partner of Israel IV. As a result Management 4 may be deemed to share voting and dispositive power with respect to the shares held by Israel IV. Management 4 disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
The securities are held by Pontifax (Cayman) IV, L.P. ("Cayman IV"). Management 4 is the ultimate general partner of Cayman IV. As a result Management 4 may be deemed to share voting and dispositive power with respect to the shares held by Cayman IV. Management 4 disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
The securities are held by Pontifax (China) IV, L.P. ("China IV"). Management 4 is the ultimate general partner of China IV. As a result Management 4 may be deemed to share voting and dispositive power with respect to the shares held by China IV. Management 4 disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
The securities are held by Pontifax Late Stage Fund, L.P. ("Late Stage"). Pontifax Late Stage GP Ltd. ("Late Stage GP") is the general partner of Late Stage and the sole shareholder of Late Stage GP is Mr. Shlomo Karako. Pursuant to Strategic Alliance Agreement, dated August 9, 2018, between Late Stage, Israel IV, Cayman IV and China IV (collectively the, "Pontifax IV Funds"), Late Stage invests side-by-side with the Pontifax IV Funds. By virtue of the strategic relationship, Management 4 may be deemed to share voting and dispositive power with respect to the shares held by Late Stage in a manner similar to the voting and investment power with respect to the shares held by each of the Pontifax IV Funds.
Each of Management 4 and Late Stage GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
/s/ Keith Regnante, Attorney-in-Fact for Pontifax Management 4 G.P. (2015) Ltd.
2020-04-13
/s/ Keith Regnante, Attorney-in-Fact for Pontifax (Israel) IV L.P.
2020-04-13
/s/ Keith Regnante, Attorney-in-Fact for Pontifax (Cayman) IV L.P.
2020-04-13
/s/ Keith Regnante, Attorney-in-Fact for Pontifax (China) IV L.P.
2020-04-13
/s/ Keith Regnante, Attorney-in-Fact for Pontifax Late Stage Fund, L.P.
2020-04-13
/s/ Keith Regnante, Attorney-in-Fact for Pontifax Late Stage GP Ltd.
2020-04-13